Articles dans des revues avec comité de lecture (182)

  1. 34. Lepida, A., Marot, A., Trepo, E., Degré, D., Moreno, C., & Deltenre, P. (2019). Systematic review with meta-analysis: automated low-flow ascites pump therapy for refractory ascites. Alimentary pharmacology & therapeutics, 50(9), 978-987. doi:10.1111/apt.15502
  2. 35. Hees, S. V., Chi, H., Hansen, B., Bourgeois, S., Vlierberghe, H. V., Serste, T., Francque, S., Wong, D., Sprengers, D., Moreno, C., Nevens, F., Janssen, H. H., & Vanwolleghem, T. (2019). Caucasian Ethnicity, but Not Treatment Cessation is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg Seroconversion. Viruses, 11(8). doi:10.3390/v11080687
  3. 36. Opstaele, L., Bielen, R., Bourgeois, S., Moreno, C., Nevens, F., Robaeys, G., & Van Vlierberghe, H. (2019). Who to screen for hepatitis c? A cost-effectiveness study in Belgium of comprehensive hepatitis c screening in four target groups. Acta Gastro-Enterologica Belgica (English ed.), 82(3), 379-387.
  4. 37. Barrail-Tran, A., Goldwirt, L., Gelé, T., Laforest, C., Lavenu, A., Danjou, H., Radenne, S., Leroy, V., Houssel-Debry, P., Duvoux, C., Kamar, N., De Ledinghen, V., Canva, V., Conti, F., Durand, F., D’Alteroche, L., Botta-Fridlund, D., Moreno, C., Cagnot, C., Samuel, D., Fougerou-Leurent, C., Pageaux, G.-P., Duclos-Vallée, J.-C., Taburet, A. M., & Coilly, A. (2019). Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort. European Journal of Clinical Pharmacology. doi:10.1007/s00228-019-02725-x
  5. 38. Zeuzem, S., Bourgeois, S., Greenbloom, S., Buti, M., Aghemo, A., Lampertico, P., Janczewska, E., Lim, S. G., Moreno, C., Buggisch, P., Tam, E., Corbett, C., Willems, W., Vijgen, L., Fevery, B., Ouwerkerk-Mahadevan, S., Ackaert, O., Beumont, M., Kalmeijer, R., Sinha, R., & Biermer, M. (2019). JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1. Hepatology. doi:10.1002/hep.30527
  6. 39. Deltenre, P., Trepo, E., Fujiwara, N., Goossens, N., Marot, A., Dubois, M., Spahr, L., Henrion, J., Moreno, C., & Hoshida, Y. (2019). Gene signature-MELD score and alcohol relapse determine long-term prognosis of patients with severe alcoholic hepatitis. Liver international. doi:10.1111/liv.14265
  7. 40. Van Hees, S., Chi, H., Hansen, B., Bourgeois, S., Van Vlierberghe, H., Serste, T., Francque, S., Wong, D., Sprengers, D., Moreno, C., Nevens, F., Janssen, H. H., & Vanwolleghem, T. (2019). Sustained off-treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue–induced HBeAg seroconversion. Journal of viral hepatitis. doi:10.1111/jvh.13084
  8. 41. Avila, M., Dufour, J. F., Gerbes, A. L., Zoulim, F., Bataller, R., Burra, P., Cortez-Pinto, H., Gao, B., Gilmore, I., Mathurin, P., Moreno, C., Poznyak, V., Schnabl, B., Szabo, G., Thiele, M., & Thursz, M. M. (2019). Recent advances in alcohol-related liver disease (ALD): Summary of a Gut round table meeting. Gut. doi:10.1136/gutjnl-2019-319720
  9. 42. Asselah, T., Alami, N. N., Moreno, C., Pol, S., Karatapanis, S., Gschwantler, M., Horsmans, Y., Elefsiniotis, I., Larrey, D., Ferrari, C., Rizzetto, M., Orlandini, A., Calleja, J. L. U. J., Bruno, S., Schnell, G., Qaqish, R. R., Redman, R., Pilot-Matias, T., Kopecky-Bromberg, S., Yu, Y., & Mobashery, N. (2019). Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE-I Part II). Health Science Reports, 2(3), e92. doi:10.1002/hsr2.92
  10. 43. Hedskog, C., Parhy, B., Chang, S., Zeuzem, S., Moreno, C., Shafran, S. S., Borgia, S. S., Asselah, T., Alric, L., Abergel, A., Chen, J. J., Collier, J., Kapoor, D., Hyland, R. R., Simmonds, P., Mo, H., & Svarovskaia, E. (2019). Identification of 19 novel hepatitis C virus subtypes-further expanding HCV classification. Open Forum Infectious Diseases, 6(3), ofz076. doi:10.1093/ofid/ofz076
  11. 44. Bataller, R., Arteel, G. G., Moreno, C., & Shah, V. H. (2019). Alcohol-related liver disease: Time for action. Journal of hepatology, 70(2), 221-222. doi:10.1016/j.jhep.2018.12.007
  12. 45. Moreno, C., Mueller, S., & Szabo, G. (2019). Non-invasive diagnosis and biomarkers in alcohol-related liver disease. Journal of hepatology, 70(2), 273-283. doi:10.1016/j.jhep.2018.11.025

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Suivant >>